BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17382973)

  • 1. Cannabinoid modulation of neuronal function after oxygen/glucose deprivation in area CA1 of the rat hippocampus.
    Youssef FF; Hormuzdi SG; Irving AJ; Frenguelli BG
    Neuropharmacology; 2007 May; 52(6):1327-35. PubMed ID: 17382973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
    Hájos N; Freund TF
    Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
    Hoffman AF; Macgill AM; Smith D; Oz M; Lupica CR
    Eur J Neurosci; 2005 Nov; 22(9):2387-91. PubMed ID: 16262678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE; Miller F; Palchik G; Deadwyler SA
    Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
    Hofmann ME; Bhatia C; Frazier CJ
    J Physiol; 2011 Aug; 589(Pt 15):3801-21. PubMed ID: 21646412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
    Bajo M; Roberto M; Schweitzer P
    J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
    Mendiguren A; Pineda J
    Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
    Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
    Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
    Pugliese AM; Traini C; Cipriani S; Gianfriddo M; Mello T; Giovannini MG; Galli A; Pedata F
    Br J Pharmacol; 2009 Jul; 157(5):818-30. PubMed ID: 19422385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity.
    Reich CG; Mihalik GR; Iskander AN; Seckler JC; Weiss MS
    Neuroscience; 2013 Dec; 253():444-54. PubMed ID: 24035826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.
    Landucci E; Scartabelli T; Gerace E; Moroni F; Pellegrini-Giampietro DE
    Neuropharmacology; 2011 Mar; 60(4):674-82. PubMed ID: 21130785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
    Németh B; Ledent C; Freund TF; Hájos N
    Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.
    Ma YL; Weston SE; Whalley BJ; Stephens GJ
    Br J Pharmacol; 2008 May; 154(1):204-15. PubMed ID: 18311186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.
    Loureiro M; Kramar C; Renard J; Rosen LG; Laviolette SR
    Biol Psychiatry; 2016 Aug; 80(3):216-25. PubMed ID: 26681496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
    Lees G; Dougalis A
    Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.